Abstract Details
|
Margi B. Patel, MD
(Baylor Scott and White)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| David G. Standaert, MD, PhD, FAAN (Univ of Alabama - Dept of Neurology) | Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Inc. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curium. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Pharmacy. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for F. Hoffman LaRoche. Dr. Standaert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Aventis. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance, Inc. Dr. Standaert has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorder Society. The institution of Dr. Standaert has received research support from Abbvie, Inc. The institution of Dr. Standaert has received research support from American Parkinson Disease Association. The institution of Dr. Standaert has received research support from National Institutes of Health. The institution of Dr. Standaert has received research support from F. Hoffman LaRoche. Dr. Standaert has received publishing royalties from a publication relating to health care. Dr. Standaert has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with National Institutes of Health. Dr. Standaert has a non-compensated relationship as a Chair, Scientific Advisory Board with American Parkinson Disease Association that is relevant to AAN interests or activities. |
| Marissa N. Dean, MD (The University of Alabama at Birmingham) | The institution of Dr. Dean has received research support from Hoffman-La Roche. The institution of Dr. Dean has received research support from Vaccinex Inc.. The institution of Dr. Dean has received research support from Abbvie, Inc.. The institution of Dr. Dean has received research support from Retrophin, Inc.. The institution of Dr. Dean has received research support from Annexon, Inc.. The institution of Dr. Dean has received research support from Neurocrine Biosciences. The institution of Dr. Dean has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Dean has received research support from CHDI Foundation. The institution of Dr. Dean has received research support from Eli Lily and Company. The institution of Dr. Dean has received research support from United States Army Medical Research and Development Command. The institution of Dr. Dean has received research support from UniQure Biopharma B.V.. The institution of Dr. Dean has received research support from Neuraly, Inc.. The institution of Dr. Dean has received research support from Praxis Precision Medicines. |